Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Censoring Survival Data01:09

Censoring Survival Data

Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different reasons...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are observed.
Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data01:16

Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data

Statistical inference techniques, paramount in hypothesis testing, differentiate into two broad categories: parametric and nonparametric statistics.
Parametric statistics, as the name suggests, assumes that data follow a specific distribution, often a normal distribution. This assumption enables robust hypothesis testing and estimation. Parametric methods, like the Student's t-test or Goodness-of-fit test, are frequently employed in biostatistics due to their robustness. For instance, comparing...
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel maternal prenatal risk index to predict mortality-weighted severe maternal morbidity at hospitalization: a retrospective cohort study.

Lancet regional health. Americas·2026
Same author

Information-Based Composite Likelihood Method for Hybrid Meta-Analysis Integrating Individual Participant Data and Aggregated Data.

Statistics in medicine·2026
Same author

Canopy2: Tumor Phylogeny Inference by Bulk DNA and Single-Cell RNA Sequencing.

Statistics in biosciences·2026
Same author

Mortality-weighted severe maternal morbidity: a novel approach to assessing maternal health outcomes.

BMC pregnancy and childbirth·2025
Same author

Pair-Feeding Study Designs Can Create Biases and Inflate Type I Error Rates: A Simulation Study.

Obesity (Silver Spring, Md.)·2025
Same author

Bayesian network meta-regression for aggregate ordinal outcomes with imprecise categories.

Journal of biopharmaceutical statistics·2025

Related Experiment Video

Updated: May 11, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Bayesian modeling and inference for clinical trials with partial retrieved data following dropout.

Qingxia Chen1, Ming-Hui Chen, David Ohlssen

  • 1Department of Biostatistics, Vanderbilt University, Nashville, TN 37232, USA.

Statistics in Medicine
|April 27, 2013
PubMed
Summary

This study introduces a new Bayesian method to analyze complex clinical trial data where patients switch treatments. The model effectively links on-protocol and off-protocol data, improving treatment effect assessment.

Keywords:
Markov chain Monte Carlointermittent missingnesslogistic regression modelmissing at randommultivariate mixed-effects model

More Related Videos

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Related Experiment Videos

Last Updated: May 11, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Area of Science:

  • Biostatistics
  • Clinical Trial Methodology
  • Longitudinal Data Analysis

Background:

  • Randomized clinical trials (RCTs) often involve patients switching from investigational treatments to standard care.
  • This 'off-protocol' data is valuable but creates complex data structures, challenging treatment effect analysis.
  • Existing models struggle to integrate per-protocol and off-protocol data effectively.

Purpose of the Study:

  • To develop a novel Bayesian method for jointly modeling longitudinal treatment measurements in RCTs with treatment switching.
  • To address complex data structures arising from patients stopping assigned treatments and switching to standard care.
  • To provide a robust framework for assessing treatment effects using both on-protocol and off-protocol data.

Main Methods:

  • Proposed a multivariate normal mixed-effects model for repeated measurements under assigned and standard treatments.
  • Utilized multivariate logistic regression for modeling treatment cessation and logistic regression for initiating standard treatment off-protocol.
  • Developed a conditional multivariate logistic regression model for complete study withdrawal, assuming non-ignorable dropout.

Main Results:

  • The novel Bayesian method successfully integrates per-protocol and off-protocol data.
  • The proposed model handles various dropout scenarios, including non-ignorable withdrawal.
  • An efficient Markov chain Monte Carlo (MCMC) sampling algorithm was developed for model implementation.

Conclusions:

  • The developed Bayesian approach offers a powerful tool for analyzing complex longitudinal data in clinical trials with treatment switching.
  • This method enhances the accurate assessment of experimental therapy effects by incorporating valuable off-protocol information.
  • The study provides a practical and efficient analytical solution for a common challenge in clinical trial data analysis.